Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.730
-0.100 (-2.07%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Revenue

In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.

Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
269.65M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.15M-18.84M-72.50%
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 2019---
Dec 31, 201820.16M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MacroGenics175.14M
Niagen Bioscience129.08M
Compugen74.00M
Cellectis63.82M
Alector13.86M
Lineage Cell Therapeutics13.08M
Surrozen11.51M
Pyxis Oncology11.04M
Revenue Rankings

WHWK News

More News